1-Piperidinecarboxylic acid, 4-(1H-benzimidazol-2-ylamino)-, ethyl ester → (1-(2-(2,2,2-trifluoroethoxy)ethyl)-1H-benzimidazol-2-yl)(piperidin-4-yl)amine

HRID 582089노트

반응식

HRID 582089 반응식
[F:1][C:2]([F:13])([F:12])[CH2:3][O:4][CH2:5][CH2:6]OS(C)(=O)=O.[NH:14]1[C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=2[N:16]=[C:15]1[NH:23][CH:24]1[CH2:29][CH2:28][N:27](C(OCC)=O)[CH2:26][CH2:25]1>>[F:1][C:2]([F:13])([F:12])[CH2:3][O:4][CH2:5][CH2:6][N:14]1[C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=2[N:16]=[C:15]1[NH:23][CH:24]1[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]1

참가 물질

3

실험 절차

Prepare by the method of Preparation 14 using 2-methanesulfonyloxyethyl 2,2,2-trifluoroethyl ether and (1H-benzimidazol-2-yl)(1-ethoxycarbonylpiperidin-4-yl)amine to give the title compound.

출처 및 근거

ORD 기록
ord-5831e1c1fd1f43e6be799f6d335bff53
출처 데이터셋
uspto-grants-1999_07
특허 번호
US05922737

반응 노트

불러오는 중…